Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02383758 · ClinicalTrials.gov registry record · NA
An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02383758 is a NA study that has completed, run by Emory University. The registered enrollment target is 22 participants.
The verdict
NCT02383758, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to try to treat bowel movement (BM) accidents differently with children with autism spectrum disorder (ASD). The study will use over-the-counter (OTC) medications to evoke predictable bowel movements. This will make it possible for investigators to use certain strategies to reward BMs in the toilet. Independence will be increased by fading out the use of medications. The investigators will also train caregivers to implement the procedures.
Interventions
- DRUG Senna
- DRUG Glycerin Suppository
- DRUG Bisacodyl suppository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-02-01 |
| Est. Completion | 2017-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02383758
The ClinicalTrials.gov registry entry for NCT02383758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Senna is the first listed.
NCT02383758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02383758 about?
NCT02383758 is a clinical study titled "An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders". The purpose of this study is to try to treat bowel movement (BM) accidents differently with children with autism spectrum disorder (ASD). The study will use over-the-counter (OTC) medications to evoke predictable bowel movements. This will make it possible for investigators to use certain strategies...
What is the current status of trial NCT02383758?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-02-01. Estimated completion is 2017-01-01.
What interventions are being tested in trial NCT02383758?
The interventions under investigation include: Senna (DRUG), Glycerin Suppository (DRUG), Bisacodyl suppository (DRUG).
Who is sponsoring clinical trial NCT02383758?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.